Effect of Performance Enhancing Drugs on Athletes Career
Abstract
Athletes use prohibited medications, drugs, or treatments with the intention of improving their performance, this is termed as doping. Doping is a very common term used in sports. It is an unethical way of enhancing performance therefore prohibited by most of the organizations. It also goes against the spirt of the game. There are many health risk factors of doping, that’s also a reason to ban doping.
The main reason why doping is banned, as these substances can have harmful and long lasting side effects related to heart, nervous system, respiratory and hormonal changes. It can lead to irregular heartbeat, High blood pressure, heart attack that may lead to death of the person. Doping also has effect on nervous system causing anxiety, insomnia, depression, aggressive behaviour, addiction with withdrawal symptoms, psychosis, tremor dizziness, stroke, etc. In many cases it also leads to respiratory problems like nose bleeding, sinusitis, etc. This may also affect hormonal changes causing infertility, Gynecomastia (enlarges breast), decrease testicular size, low sex drive, acromegaly (coarse bone in face, hands and feet, cancer
Downloads
References
British Medical Association. 2002. Drugs in sport: the pressure to perform, London: BMJ Publishing. [Google Scholar]
Dodge, T. and Jaccard, J.J. 2008. Is abstinence an alternative? Predicting adolescent athletes’ intentions to use performance enhancing substances. Journal of health psychology, 13 (5): 703–711. [Google Scholar]
Donovan, R.J. 2002. A conceptual framework for achieving performance enhancing drug compliance in sport. Sports medicine, 32(4): 269–284. [Google Scholar]
Haugen, K.K. 2004. The performance enhancing drug game. Journal of sports economics, 5(1): 67–86. [Google Scholar]
Kayser, B., Mauron, A. and Miah, A. 2007. Current anti‐doping policy: a critical appraisal. BMC medical ethics, 8: 2 [Google Scholar]
Louviere, J. and Woodworth, G. 1983. Design and analysis of simulated consumer choice or allocation experiments: an approach based on aggregate data. Journal of marketing research, 20: 350–367. [Crossref], [Web of Science ®], [Google Scholar]
Maennig, W. 2002. On the economics of doping and corruption in international sports. Journal of sports economics, 3(1): 61–89. [Google Scholar]
Mazanov, J. 2009b. Debating the role of drugs in sport: a reader. Sport in society, 12 (3): 296–312. [Google Scholar]
Mazanov, J. and McDemott, V. 2009. The case for a social science of drugs in sport. Sport in society, 23(2): 276–295. [Google Scholar]
Morgan, W.J. 2006. Fair is fair, or is it? A moral consideration of the doping wars in American sport. Sport in society, 9(2): 177–198. [Google Scholar]
O’Leary, J. 2001. “Doping solutions and the problem with ‘problems’”. In Drugs and doping in sport: sociolegal perspectives, Edited by: O’Leary, J. 255–267. London: Cavendish Publishing. [Google Scholar]
Petroczi, A. and Aidman, E. 2008. Psychological drivers of doping: the life‐cycle model of performance enhancement. Substance abuse treatment, prevention and policy, 3: 7 [Crossref], [PubMed], [Web of Science ®], [Google Scholar]
Petroczi, A. 2008. Comfort in big numbers: does over‐estimation of doping prevalence in others indicate self‐involvement?. Journal of occupational medicine and toxicology, 3: 19 [Crossref], [PubMed], [Google Scholar]
Savulescu, J., Foddy, B. and Clayton, M. 2004. Why we should allow performance enhancing drugs in sport. British journal of sports medicine, 38: 666–670. [Crossref], [PubMed], [Web of Science ®], [Google Scholar]
Sharpe, K. 2009. The economics of drugs in sport. Sport in society, 12(3): 344–355. [Google Scholar]
Stewart, B. and Smith, A. 2008. Drug use in sport: implications for public policy. Journal of sport and social issues, 32(3): 278–298. [Google Scholar]
Strelan, P. and Boekmann, R.J. 2003. A new model for understanding performance enhancing drug use by elite athletes. Journal of applied sport psychology, 15: 176–183. [Taylor & Francis Online], [Web of Science ®], [Google Scholar]
Strelan, P. and Boekmann, R.J. 2006. Why drug testing in elite sport does not work: perceptual deterrence theory and the role of personal moral beliefs. Journal of applied social psychology, 36(12): 2909–2934. [Google Scholar]
WADA. 2009. World anti‐doping code, Canada: WADA. [Google Scholar]
SportsMedToday.com; https://www.sportsmedtoday.com/doping-va-119.htm#:~:text=%E2%80%9CDoping%E2%80%9D%20refers%20to%20the%20use,to%20improve%20their%20athletic%20performance. Visited on 20th May 2021
World Anti-doping Code https://www.wada-ama.org/en/questions-answers/world-anti-doping-code#:~:text=The%20World%20Anti%2DDoping%20Code%20(Code)%20is%20the%20document,sport%20organizations%20and%20public%20authorities.visited on 22nd May 2021
.Hatton C, Green G, Ambrose P. Performance-Enhancing Drugs: Understanding the Risks. Phys Med Rehabil clin N Am 2014;25(4):897–913.
Madden CC. Drugs and Doping in Athletes. In: Netter’s Sports Medicine. 1st ed. Philadelphia, PA: Saunders/Elsevier; 2010.
Backhouse, S. 2007. Attitudes, behaviours, knowledge and education – drugs in sport: past, present and future, Montreal: WADA. [Google Scholar]
